Why the study?
Is there an increased rate of chromosome 22q11 deletions among patients with early-onset psychosis?
Is there an increased rate of chromosome 22q11 deletions among patients with early-onset psychosis?
Chromosome 22q11 deletions (Velo-cardio-facial syndrome) may be less frequent among patients with psychosis than previously suggested and are not increased in early-onset psychosis.
Answers are grounded in this paper and cite their sources.
No increase in 22q11 deletions in early-onset psychosis; challenges prior estimates but leaves screening utility open.
BACKGROUND: Velo-cardio-facial syndrome (VCFS) is associated with interstitial deletions of chromosome 22q11. About 30% of patients with VCFS have psychosis, and the rate of these deletions in schizophrenia has been reported to be about 1%. Even higher rates of VCFS deletions have been reported for childhood-onset schizophrenia. AIMS: To test the hypothesis that there is an increased rate of VCFS among patients with early-onset psychosis (age at onset <18 years). We screened 192 early-onset patients and 329 patients with adult-onset schizophrenia. METHOD: We genotyped the patients and 444 healthy controls for hemizygosity of five microsatellite markers and one single nucleotide polymorphism that map to the 22q11-deleted region. RESULTS: One patient had a VCFS deletion, confirmed with semi-quantitative polymerase chain reaction. None of the controls showed a pattern of genotypes consistent with hemizygosity. CONCLUSIONS: VCFS may be less frequent among patients with psychosis than previously suggested; this rate is not increased among early-onset patients.
No takes yet. Share an insight, caveat, or question.
Ivanov et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: